Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.12%) 5 333.75 points
Dow Jones Futures
(0.04%) 40 154 points
Nasdaq Futures
(0.20%) 18 672 points
Oil
(-0.35%) $79.78
Gas
(0.84%) $2.65
Gold
(0.88%) $2 438.70
Silver
(2.18%) $31.94
Platinum
(-0.29%) $1 086.80
USD/EUR
(0.08%) $0.920
USD/NOK
(-0.01%) $10.67
USD/GBP
(0.07%) $0.788
USD/RUB
(-0.54%) $90.48

Realtime updates for Regulus Therapeutics Inc [RGLS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated17 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 2.00

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):
Profile picture for Regulus Therapeutics Inc

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States...

Stats
Today's Volume 263 460
Average Volume 3.23M
Market Cap 130.93M
EPS $0 ( 2024-05-09 )
Next earnings date ( $0 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.270
ATR14 $0.00500 (0.25%)
Insider Trading
Date Person Action Amount type
2024-05-16 Collier Kathryn J Buy 30 000 Stock Option (Right to Buy)
2024-05-16 Nunn Jason Raleigh Buy 30 000 Stock Option (Right to Buy)
2024-05-16 Baltimore David Buy 30 000 Stock Option (Right to Buy)
2024-05-16 Rosen Hugh Buy 30 000 Stock Option (Right to Buy)
2024-05-16 Witz Pascale Buy 30 000 Stock Option (Right to Buy)
INSIDER POWER
98.60
Last 89 transactions
Buy: 12 510 605 | Sell: 39 678

Volume Correlation

Long: -0.07 (neutral)
Short: 0.29 (neutral)
Signal:(61.615) Neutral

Regulus Therapeutics Inc Correlation

10 Most Positive Correlations
ADN0.947
CRDF0.939
AIRG0.927
EBAY0.925
NODK0.922
BYSI0.922
CPRT0.918
MNMD0.916
GIFI0.915
EQRR0.915
10 Most Negative Correlations
TCPC-0.923
RGF-0.917
CLEU-0.914
QNRX-0.912
HRZN-0.911
TWKS-0.909
RETO-0.897
UONEK-0.896
UONE-0.895
CNXC-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regulus Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.50
( weak negative )
The country flag -0.55
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.43
( neutral )
The country flag 0.00
( neutral )
The country flag 0.76
( moderate )

Regulus Therapeutics Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-227 000 (0.00 %)
EPS: $-1.580
FY 2023
Revenue: $0
Gross Profit: $-227 000 (0.00 %)
EPS: $-1.580
FY 2022
Revenue: $0
Gross Profit: $-122 000 (0.00 %)
EPS: $-1.860
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-3.19

Financial Reports:

No articles found.

Regulus Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Regulus Therapeutics Inc

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators